-
1
-
-
0020374438
-
Inhibition of neutrophil migration by etretinate and its main metabolite
-
DOI 10.1111/j.1365-2133.1982.tb00528.x
-
L. Dubertret, C. Lebreton, and R. Touraine Inhibition of neutrophil migration by etretinate and its main metabolite Br J Dermatol 107 1982 681 685 (Pubitemid 13238867)
-
(1982)
British Journal of Dermatology
, vol.107
, Issue.6
, pp. 681-685
-
-
Dubertret, L.1
Lebreton, C.2
Touraine, R.3
-
2
-
-
0024404347
-
Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro
-
P. Dupuy, M. Bagot, and M. Heslan Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro J Invest Dermatol 93 1989 455 459 (Pubitemid 19225487)
-
(1989)
Journal of Investigative Dermatology
, vol.93
, Issue.4
, pp. 455-459
-
-
Dupuy, P.1
Bagot, M.2
Heslan, M.3
Dubertret, L.4
-
3
-
-
27644547405
-
Acitretin is converted to etretinate only during concomitant alcohol intake
-
F. Gronhoj Larsen, B. Steinkjer, and P. Jakobsen Acitretin is converted to etretinate only during concomitant alcohol intake Br J Dermatol 145 2001 1028 1029
-
(2001)
Br J Dermatol
, vol.145
, pp. 1028-1029
-
-
Gronhoj Larsen, F.1
Steinkjer, B.2
Jakobsen, P.3
-
4
-
-
0022389020
-
Etretinate (Tigason, Europe; Tegison, USA) in psoriasis: Advantages of low doses progressively increased
-
L. Dubertret Etretinate (Tigason, Europe; Tegisonnm USA) in psoriasis. Advantages of low doses progressively increased J Am Acad Dermatol 13 1985 830 831 (Pubitemid 16245160)
-
(1985)
Journal of the American Academy of Dermatology
, vol.13
, Issue.5
, pp. 830-831
-
-
Dubertret, L.1
Ellis, C.N.2
-
5
-
-
0024511179
-
Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis
-
P. Berbis, J.M. Geiger, C. Vaisse, and C. Rognin Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis Dermatologica 178 1989 88 92 (Pubitemid 19058799)
-
(1989)
Dermatologica
, vol.178
, Issue.2
, pp. 88-92
-
-
Berbis, P.1
Geiger, J.-M.2
Vaisse, C.3
Rognin, C.4
Privat, Y.5
-
7
-
-
0024396992
-
Side-effect profile of acitretin therapy in psoriasis
-
A.K. Gupta, M.T. Goldfarb, C.N. Ellis, and J.J. Voorhees Side-effect profile of acitretin therapy in psoriasis J Am Acad Dermatol 20 1989 1088 1093 (Pubitemid 19151521)
-
(1989)
Journal of the American Academy of Dermatology
, vol.20
, Issue.6
, pp. 1088-1093
-
-
Gupta, A.K.1
Goldfarb, M.T.2
Ellis, C.N.3
Voorhees, J.V.4
-
8
-
-
0029063628
-
The safety of etretinate as long-term therapy for psoriasis. Results of the etretinate follow-up study
-
R.S. Stern, E. Fitzgerald, and C.N. Ellis The safety of etretinate as long-term therapy for psoriasis. Results of the etretinate follow-up study J Am Acad Dermatol 33 1995 44 52
-
(1995)
J Am Acad Dermatol
, vol.33
, pp. 44-52
-
-
Stern, R.S.1
Fitzgerald, E.2
Ellis, C.N.3
|